Profile for European Patent Office Patent: 0521471
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | 300125 | ⤷ Start Trial |
| Luxembourg | 91042 | ⤷ Start Trial |
| United Kingdom | SPC/GB03/033 | ⤷ Start Trial |
| Denmark | CA 2003 00024 | ⤷ Start Trial |
| Switzerland | C00521471/01 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 0521471
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
